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Abstract 
 
The aim of the present research is to determine the common causes of chronic voice 
disorders,  to  determine  the  sociodemographic  and  behavioral  risk  factors  for  patients  with 
chronic voice disorders and to study the QOL of them. The ORL Outpatient Clinics, Al-Azhar 
University hospitals were chosen to carry out this study. A total of 495 patients with chronic 
voice disorders and a control group of the same number were enrolled in the study. A case-
control,  hospital  based  study  design  was  used.  The  most  common  causes  of  chronic  voice 
disorders among these patients were chronic laryngitis (35.6%), vocal fold nodules (22.6%), 
functional dysphonia (18.6%) and vocal fold polyps (13.5%). The 25-44 years age group, low 
social class, sale man occupation, urban residence and female gender were the most important 
significant sociodemographic risk factors for patients with chronic voice disorders (ORs= 4.17, 
2.01,  1.71,  1.60  and  1.32,  respectively).  The  +ve  reflux  symptoms  index,  voice  abuse  and 
smoking  were  an  important  significant  clinical  risk  factors  (ORs=16.94,  8.33  and  6.01, 
respectively). Also, patients with chronic voice disorders had a significantly poorer self-reported 
health related domain scores than the controls on all eight SF-36 domains (P=0.00). Moreover, 
patients  with  chronic  voice  disorders  due  to  different  laryngeal  diseases  had  a  significantly 
poorer self-reported health related domain scores than the controls on all eight SF-36 domains 
except in the miscellaneous diseases group. 
 
Introduction 
 
         Voice is one of the unique attributes 
of humans. It provides a principal means of 
communication,  emotional  expression  and 
identity  (Solomon  et  al.,  2003).  Voice 
disorders  exist  when  quality,  pitch  or 
loudness  differs  from  others  of  the  same 
age,  gender,  cultural  background  and 
geographic  location,  thereby  drawing 
attention  to  the  speaker.  Voice  disorders 
may  results  from  changes  in  the  structure 
and/or  function  of  the  laryngeal  mecha-
nism  (Stemple  et  al.,  1996).  Laryngeal 
pathologies  that  cause  voice  disorders 
comprise  a  group  of  diseases;  the  most 
frequent  are  chronic  laryngitis,  nodules, 
polyps,  edema,  functional  dysphonia  ...etc 
(Herrington-Hall et al., 1988 and Coyle et 
al.,  2001).  Epidemiological  reports  on  the 
occurrence of chronic voice disorders have 
been  few  in  number.  Also,  reports  are 
relatively  scarce,  outdated  and  provide 
conflicting  information  (Miller  and 
Verdolini,  1995;  Smith  et  al.,  1997  and 
Titze et al., 2007). An update of such data 
may  lead  to  further  identification  of 
subjects at risk for developing chronic voice 
disorders,  information  to  enhance  public 
education  about  voice  disorders  and 
identifying  of  risk  factors  associated  with 
various demographic and clinical variables 
(Coyle et al., 2001 and Titze et al., 2007). 
         Moreover, over the past 20 years there 
has  been  an  increased  recognition  of  the 
patient's  point  of  view  as  an  important 
component in the assessment of health care 
outcomes (Watson et al., 1996). Quality of 
life (QOL) has become accepted as an end 
point in clinical research trials, as interest in 
patients'  experiences  and  preferences  has 
grown (Patrick and Bergner, 1990). Reports 
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of QOL end points remain uncommon and 
quality of reporting  is often poor  (Sanders 
et al., 1998). Also, the term QOL is often 
used  vaguely  and  without  clear  definition 
(Fallowfield,  1996).  The  most  accepted 
definition  of  QOL  is  "a  measure  of  the 
optimum  energy  or  force  that  endows  a 
person with the power to cope successfully 
with  the  full  range  of  challenges 
encountered  in  the  real  world".  The  term 
QOL  applies  to  all  individuals,  regardless 
of illness or handicap, on the job, at home 
or in leisure activities (Gotay et al., 1992). 
The  perception  of  QOL  varies  between 
individuals  and  it  is  dynamic  within  them. 
QOL  in  relation  to  health  is  the  gap 
between our expectations and experience of 
health.  People  with  different  expectations 
report a different QOL even when the same 
clinical  condition  is  present.  Current 
measures  for  QOL  do  not  account  for 
expectations  of  health  (Guillemin  et  al., 
1993 and Carr et al., 2006). There are many 
instruments  that  have  been  proposed  to 
measure  QOL;  generic  measures  as  the 
sickness  impact  profile  (Bergner  et  al., 
1981).  Other  methods  include  measures 
focusing on a single aspect such as pain or 
anxiety  and  individualized  measures,  in 
which  patients  define  and  rate  the  most 
important aspects of their QOL (Begg et al., 
1996). 
         People  with  dysphonia  seem  to 
experience employment, lifestyle and social 
difficulties as a direct consequence of their 
voice disorders. Assessments of the impact 
of dysphonia on the patient have focused on 
psychological  and  voice  outcomes.  Any 
attempts  to  quantify  the  effects  of  the 
disorder  on  general  health  and  quality  of 
life  have  relied  upon  open-ended  patient 
reports (Scott et al., 1997). There have been 
few  studies  of  the  QOL  of  patients  with 
dysphonia  (Benninger  et  al.,  1998  and 
Spector et al., 2001). 
         The aim of the present research is to 
determine  the  most  common  causes  of 
voice  disorders,  to  define  the  sociodem-
ographic,  behavioral  and  clinical  risk 
factors  for  patients  with  chronic  voice 
disorders  and  to  study  the  QOL  of  these 
patients with chronic voice disorders due to 
laryngeal diseases. 
 
Subjects And Methods 
 
         This study was carried out in the Oto-
Rhino-Laryngelogy  (ORL)  Out-patient 
Clinics,  Al-Azhar  University  Hospitals  in 
Cairo  and  Assiut.  A  total  number  of  495 
patients with chronic voice disorders due to 
laryngeal diseases and an equal number of 
adult  controls  were  enrolled  in  this  study. 
The  control  group  was  chosen  randomly 
from adults attending the clinics for reasons 
other  than  chronic  voice  disorders  and 
found  to  be  free.  A  case-control,  hospital 
based study design was chosen to carry out 
this study. Chronic was defined as a period 
≥4  weeks.  The  chronic  voice  disorder 
patients and controls were adults, their age 
was  ≥18  years.  The  purpose  of  the  study 
was explained to the patients and controls. 
A  verbal  consent  of  both  of  them,  to 
participate in the study, was given. 
         Clinical  examinations  had  been  done 
for the patient and control groups. Also, the 
required  investigations  had  been  done  for 
the patients. Laryngeal diseases that caused 
chronic  voice  disorders  were  diagnosed 
through  specific  protocol  according  to  El-
Moselhy  et  al.  (2004).  Also,  a  comprehe-
nsive questionnaire was designed to contain 
data relevant to the topic of the study. 
         The reflux symptoms index (RSI) was 
used  to  determine  presence  of  reflux 
symptoms. Normative data suggests that a 
RSI of ≥10 is clinically significant. Subjects 
were classified as having +ve RSI, if scored 
≥10 and –ve RSI, if scored <10. Presence of 
+ve or -ve RSI was related to presence or 
absence of laryngeal pathologies (Belafsky 
et al., 2002). 
         We used the medical outcomes study 
36-item  short  form  (SF-36)  to  study  the 
QOL  of  the  patients  with  chronic  voice 
disorders  due  to  laryngeal  diseases.  SF-36 
is  one  of  the  most  widely  accepted,  used 
and  psychometrically  sound  instrument 
designed  to  measure  general  health  items 
(Watson  et  al.,  1996).  The  reliability  and 
validity  of  the  SF-36  have  been 
documented.  Also,  health  functioning 
changed  in  the  hypothesized  direction  with 
increased  age,  socioeconomic  status  and 
disease  status  in  a  population-based  study 
suggested that the instrument is sensitive to  
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changes  in  the  health  of  the  general 
population  (Garratt,  2002).  It  allows 
investigators to explore  the interaction  and 
relative effect of multiple health conditions 
in the same patient. The SF-36 is containing 
36 questions; each patient is scored from 0 
(worst) to 100 (best) on 8 separate domains 
of  health-related  QOL.  These  domains 
include physical  functioning  (PF),  physical 
limitation  (PL),  bodily  pain  (BP),  general 
health  (GH),  vitality  (VT),  social  functio-
ning  (SF),  role  functioning-emotional  (RE) 
and mental health (MH). The questionnaire 
is scored according to published algorithms 
and  it  takes  about  10  minutes  to  be 
complete (Hemingway et al., 1997). These 
scales  are  ordered  according  to  the  degree 
to  which  they  measure  physical  versus 
mental  health.  The  36-item  question  is 
distributed  over  the  8-health  domains.  The 
SF-36  quantifies  a  broad  range  of  health 
issues  and  is  thus  acceptable  for  an 
exploratory  study  on  QOL  in  conditions 
that may be anticipated to affect patients in 
a  variety  of  ways  (Ware  et  al.,  1993). 
Normative data are  the key to  determining 
whether  a  group  or  an  individual  scores 
below  or  above  the  average  for  their 
country,  age  or  sex  (Fitzpatrick  et  al., 
2001). The chronic form of the SF-36 was 
used  to  study  the  impact  of  chronic  voice 
disorders due to laryngeal diseases on QOL. 
Impact  of  chronic  voice  disorder  was 
compared  with  control  group,  and  then 
different  etiological  pathologies  were 
compared separately with the control group. 
         Chi-square (χ2), t-test and odds ratio 
(OR) were used as tests of significance. The 
significance level for χ2 and t was accepted 
if  P-value  ≤0.05  while,  OR  was  weighted 
according  to  value  of  the  95%  confidence 
interval  (CI)  or  exact  confidence  limits 
(ECL). 
 
Results 
 
         Table  (1)  shows  the  frequency 
distribution  of  chronic  voice  disorder 
patients according to the etiology. It is clear 
that  chronic  laryngitis  was  the  most 
common  cause  (35.6%)  of  chronic  voice 
disorders.  Vocal  fold  nodules  (22.6%), 
functional  dysphonia  (18.6%),  vocal  fold 
polyps  (13.5%)  and  a  group  of 
miscellaneous  conditions  (9.7%)  were  the 
other  etiological  causes  of  chronic  voice 
disorders.  
         Table  (2)  details  the  distribution  of 
chronic voice  disorder patients  and  control 
group  according  to  their  sociodemographic 
risk factors. As regard sex, female sex was 
found  to  be  a  significant  risk  factor  for  a 
subject  to  be  a  patient  with  chronic  voice 
disorders;  females  were  56.2%  (OR=1.32, 
95% CI:  1.02-1.71). Also,  25-44 year  age 
group  was  found  to  be  a  significant  risk 
factor  for  a  subject  to  be  a  patient  with 
chronic voice disorders; the patients in this 
group  were  44.8%  (OR=1.33,  95%  CI: 
1.02-1.73).  At  the  same  time,  some 
occupations  were  found  to  be  significant 
risk factors for chronic voice disorders. The 
ORs  for  house  wife's,  factory  workers, 
teachers,  sale  men  and  retirees  were  1.38, 
95%  CI:  1.01-1.89;  1.46,  95%  CI:  1.01-
2.09; 1.51, 95% CI: 1.01-2.27; 1.71, 95% 
CI: 1.02-2.86 and 1.69, 95% CI: 1.08-2.65; 
respectively.  Moreover,  low  social  class 
was  a  significant  risk  factor  for  chronic 
voice  disorders  (OR=2.01,  95%  CI:  1.54-
2.62).  Lastly,  urban  residence  was  a 
significant  risk  factor  for  chronic  voice 
disorders (OR=1.60, 95% CI: 1.04-2.47). 
         Table (3) sssshows the distribution of 
chronic voice  disorder patients  and  control 
group according to behavioral risk factors. 
As regard voice abuse, it was found to be a 
significant risk factor for a subject to be a 
patient  with  chronic  voice  disorders 
(OR=8.33, 95% CI: 5.97-11.64). Moreover, 
smoking  was  a  significant  risk  factor  for 
chronic voice disorders (OR=6.01, 95% CI: 
2.29-3.95).  Also,  alcohol  intake  was  a 
significant risk factor for a subject to be a 
patient  with  chronic  voice  disorders 
(OR=2.90, 95% ECL: 1.08-9.05).  
         Table  (4)  clears  the  distribution  of 
chronic voice  disorder patients  and  control 
group  according  to  reflux  symptom  index 
risk  factor.  RSI  was  found  to  be  a 
significant risk factor for a subject to be a 
patient  with  chronic  voice  disorders 
(OR=16.94, 95% CI: 11.80-24.38). 
         Table  (5)  demonstrates  the  distrib-
ution  of  chronic  voice  disorder  patients 
according  to  their  sociodemo-graphic  risk 
factors. As respect sex, females were found 
to be significantly more common among all 
groups  of  the  patients  with  chronic  voice Risk Factors And Quality Of Life………  
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disorders except the miscellaneous diseases 
group. Females were 55.1%, 57.1%, 65.2%, 
52.2% and 45.8% in the chronic laryngitis, 
vocal  fold  nodules,  functional  dysphonia, 
vocal  fold  polyps  and  miscellaneous 
diseases  groups;  respectively.  Also,  25-44 
year  age  group  was  found  to  be  the  most 
common  age  to  represent  all  patients  with 
chronic  voice  disorders;  the  chronic 
laryngitis  (38.6%),  vocal  fold  nodules 
(68.8%), functional dysphonia (42.4%) and 
vocal  fold  polyps  (43.3%).  While,  the 
patients  in  miscellaneous  diseases  group 
were  more  present  in  the  45-64  year  age 
group,  54.2%.  Moreover,  the  house  wife 
and factory worker were the most common 
occupations  found  among  patients  with 
chronic  voice  disorders.  The  house  wife's 
were more common in groups of vocal fold 
nodules  (29.5%),  functional  dysphonia 
(32.6%)  and  vocal  fold  polyps  (31.3%). 
While, factory workers were more common 
in groups of chronic laryngitis (26.7%) and 
vocal  fold  polyps  (31.3%).  Also,  the 
patients  of  miscellaneous  diseases  group 
were  more  common  in  the  retired  group 
(70.8%). As regard social class, low social 
class  was  found  to  be  non-significantly 
more  common  among  all  groups  of  the 
patients with chronic voice disorders except 
the  miscellaneous  diseases  group.  Lastly, 
all  groups  of  patients  with  chronic  voice 
disorders  had  urban  residence  with  a 
statistically significant difference; the vocal 
fold nodules (97.3%), functional dysphonia 
(94.6%), vocal fold polyps (91.1%), chronic 
laryngitis  (88.6%)  and  miscellaneous 
diseases group (83.3%). 
         Table  (6)  illustrates  the  mean  and 
standard deviation of chronic voice disorder 
patients and control group according to SF-
36 QOL domain scores. All the means and 
standard  deviations  of  the  eight  domain 
scores of the SF-36 QOL of chronic voice 
disorder patients were less than that of the 
controls  with  statistically  significant 
differences (P=0.000). 
         Table  (7)  shows  the  means  and 
standard  deviations  of  different  groups  of 
chronic voice  disorder patients  and  control 
group according to the SF-36 QOL domain 
scores. As respect chronic laryngitis, vocal 
fold  nodules,  functional  dysphonia  and 
vocal fold  polyps; the  means and  standard 
deviations of the eight domain scores of SF-
36 QOL were less than that of the controls 
with statistically significant differences. As 
regard  the  miscellaneous  diseases  group, 
the  means  and  standard  deviations  of  the 
eight  domain  scores  of  the  SF-36  QOL 
were  less  than  that  of  the  controls  with 
statistically  significant  differences  except 
that of bodily pain (P=0.09). Patients with 
functional  dysphonia  scored  the  lowest 
scores in all of the eight domains of the SF-
36  QOL  except  physical  functioning.  On 
the  other  hand,  patients  with  vocal  fold 
nodules scored  the  highest  scores  in  all  of 
the eight domains of the SF-36 QOL except 
social  functioning.  But,  patients  with 
chronic laryngitis scored the lowest score in 
physical  functioning  domain  of  the  SF-36 
QOL. 
 
Table (1): Frequency distribution of chronic voice disorder patients according to 
                  the etiology. 
 
Etiology 
Chronic voice disorder  
patients (n=495) 
NO.  Percent 
Chronic laryngitis 
Vocal fold nodule 
Functional dysphonia 
Vocal fold polyp 
Miscellaneous: 
    Larynoscleroma  
    Vocal fold paralysis 
    Bowed vocal fold 
    Reinke's edema 
    Neurogenic dysphonia 
176 
112 
92 
67 
48 
13 
12 
10 
9 
4 
35.6 
22.6 
18.6 
13.5 
9.7 
2.6 
2.4 
2.0 
1.8 
0.8 E. A. El-Moselhy et al 
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Table (2): Distribution of chronic voice disorder patients and control group  
                  according to sociodemographic risk factors. 
 
 
 
Variable 
 
Chronic  
voice 
disorder 
(n=495) 
Control 
group 
(n=495)  OR (95% CI) 
NO.  %  NO.  % 
Sex: 
Female  
Male 
 
278 
217 
 
56.2 
43.8 
 
244 
251 
 
49.3 
50.7 
 
1.32 (1.02-1.71) 
0.76 (0.59-0.98) 
Age (years): 
18-24 
25-44 
45-64 
                    ≥65   
 
89 
205 
174 
27 
 
18.0 
41.4 
35.1 
5.5 
 
108 
172 
167 
48 
 
21.8 
34.8 
33.7 
9.7 
 
0.79 (0.57-1.09) 
1.33 (1.02-1.73) 
1.06 (0.81-1.40) 
0.54 (0.32-0.90) 
Occupation: 
House wife 
Retired 
Factory worker 
Sale man 
Teacher 
Unemployed 
Driver 
Other 
 
122 
61 
98 
46 
72 
29 
24 
43 
 
24.6 
12.3 
19.8 
9.3 
14.6 
5.9 
4.8 
8.7 
 
95 
38 
59 
28 
50 
71 
17 
137 
 
19.2 
7.7 
11.9 
5.7 
10.1 
14.3 
3.4 
27.7 
 
1.38 (1.01-189) 
1.69 (1.08-2.65) 
1. 46 (1.01-2.09) 
1.71 (1.02-2.86) 
1.51 (1.01-2.27) 
0.37 (0.23-0.60) 
1.43 (0.73-2.83) 
0.25 (0.33-0.56) 
Social class: 
Low 
Middle 
High 
 
247 
198 
50 
 
49.9 
40.0 
10.1 
 
164 
249 
82 
 
33.1 
50.3 
16.6 
 
2.01 (1.54-2.62) 
0.66 (0.51-0.85) 
0.57 (0.38-0.84) 
Residence: 
Urban  
Rural 
 
453 
42 
 
91.5 
8.5 
 
431 
64 
 
87.1 
12.9 
 
1.60 (1.04-2.47) 
0.62 (0.41-0.96) 
 
Table (3): Distribution of chronic voice disorder patients and control group  
                  according to behavioral risk factors. 
 
 
Variable 
 
Chronic  voice 
disorder (n=495) 
Control group 
(n=495)  OR (95% CI) 
OR (95% ECL)*  NO.  %  NO.  % 
Voice abuse: 
Yes 
 
267 
 
53.9 
 
61 
 
12.3 
 
8.33 (5.97-11.64) 
Smoking: 
Yes 
 
271 
 
54.8 
 
142 
 
28.7 
 
6.01 (2.29-3.95) 
Alcohol intake: 
Yes 
 
17 
 
3.4 
 
9 
 
1.8 
 
2.90 (1.08-9.05)* 
 
Table (4): Distribution of chronic voice disorder patients and control group  
                  according reflux symptoms index (RSI) risk factor. 
 
Reflux  
symptoms  
index 
Chronic  voice 
disorder (n=495) 
Control group 
(n=495) 
 
OR (95% CI) 
NO.  %  NO.  % 
+ve RSI 
-ve RSI 
322 
173 
65.1 
34.9 
49 
446 
9.9 
90.1 
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Table (5): Distribution of chronic voice disorder patients due to different chronic    
                  laryngeal diseases according to their sociodemographic risk factors. 
 
 
 
Variable 
 
 
Chronic 
laryngitis 
(n=176) 
Vocal fold    
nodule 
(n=112) 
Functional 
dysphonia 
(n=92) 
Vocal fold    
Polyp 
(n=67) 
Miscellaneous 
conditions 
(n=48)  χ2 
P-
value 
NO.  %  NO.  %  NO.  %  NO.  %  NO.  % 
Sex: 
Male 
Female 
 
79 
97 
 
44.9 
55.1 
 
48 
64 
 
42.9 
57.1 
 
32 
60 
 
34.8 
65.2 
 
32 
35 
 
47.8 
52.2 
 
26 
22 
 
54.2 
45.8 
 
59.61 
 
0.011 
Age (years): 
18-24 
25-44 
45-64 
        ≥65   
 
36 
68 
64 
8 
 
20.5 
38.6 
36.4 
4.5 
 
25 
77 
9 
1 
 
22.3 
68.8 
8.0 
0.9 
 
16 
39 
34 
3 
 
17.4 
42.4 
37.0 
3.2 
 
11 
29 
23 
4 
 
16.4 
43.3 
34.3 
6.0 
 
0 
5 
26 
17 
 
0.0 
11.4 
54.2 
35.4 
 
12.92 
51.974
3.4472.
80 
 
0.0160.
000 
0.0000.
000 
Occupation: 
House wife 
Retired 
Factory worker 
Sale man 
Teacher 
Unemployed 
Driver 
Other 
 
34 
6 
47 
26 
22 
13 
12 
16 
 
19.3 
3.4 
26.7 
14.8 
12.5 
7.4 
6.8 
9.1 
 
33 
9 
19 
8 
23 
6 
5 
9 
 
29.5 
8.0 
17.0 
7.1 
20.5 
5.4 
4.5 
8.0 
 
30 
7 
9 
8 
22 
6 
4 
6 
 
32.6 
7.6 
9.8 
8.7 
23.9 
6.5 
4.4 
6.5 
 
21 
5 
21 
3 
5 
3 
3 
6 
 
31.3 
7.5 
31.3 
4.5 
7.5 
4.5 
4.5 
8.9 
 
4 
34 
2 
1 
0 
1 
0 
6 
 
8.3 
70.8 
4.2 
2.1 
0.0 
2.1 
0.0 
12.5 
 
15.73 
170.3 
24.681
1.73 
21.20 
2.34 
4.03 
1.53 
 
0.003 
0.0000.
000 
0.0190.
000 
0.673 
0.401 
0.822 
Social class: 
Low 
Middle 
High 
 
81 
73 
22 
 
46.0 
41.5 
12.5 
 
62 
38 
12 
 
55.4 
33.9 
10.7 
 
46 
39 
7 
 
50.0 
42.4 
7.6 
 
37 
24 
6 
 
55.2 
35.8 
9.0 
 
21 
24 
3 
 
43.8 
50.0 
6.2 
 
3.88 
4.59 
1.67 
 
0.422 
0.332 
0.614 
Residence: 
Urban  
Rural 
 
156 
20 
 
88.6 
11.4 
 
109 
3 
 
97.3 
2.7 
 
87 
5 
 
94.6 
5.4 
 
61 
6 
 
91.1 
8.9 
 
40 
8 
 
83.3 
16.7 
 
59.11 
 
0.017 
 
Table (6): Mean and standard deviation of the chronic voice disorder patients and  
                  control group according to short form-36 QOL domain score. 
 
P-value  t  Controls    
mean ± SD 
Patients    
mean ± SD  SF-36 domain   ٍscore 
 0.000  21.747  83.91 ± 12.47  64.48 ± 15.48  Physical functioning 
 0.000  32.770  84.76 ± 12.51  57.38 ± 13.75  Physical limitation 
0.000  15.175  77.79 ± 13.75  63.77 ± 15.28  Bodily Pain 
0.000  15.566  74.98 ± 15.79  59.80 ± 14.88  General health 
0.000  19.139  70.81 ± 15.56  53.71 ± 12.37  Vitality 
0.000  17.667  87.53 ± 11.38  72.73 ± 14.76  Social functioning 
0.000  21.509  85.80 ± 13.87  65.05 ± 16.38  Emotional limitation 
0.000  11.033  76.43 ± 16.46  65.44 ± 14.80  Mental health 
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Table  (7):  Mean  and  standard  deviation  of  different  causes  of  chronic  voice                   
disorder patients and control group according to short form-36 QOL domain 
score.  
 
Controls 
Mean ± SD 
Miscellan. 
Mean ± SD 
P-value 
VFP 
Mean ± SD 
P-value 
FD 
Mean ± SD 
P-value 
VFN 
Mean ± SD 
P-value 
Ch Laryng. 
Mean ± SD 
P-value 
SF-36 domain 
  ٍscore 
83.91±12.47  64.17±16.32 
P= 0.000 
66.57±13.19 
P= 0.000 
61.92±13.87 
P= 0.000 
72.11±14.34 
P= 0.000 
60.54±15.37 
P= 0.000 
Physical 
functioning 
84.76±12.51  55.75±9.78 
P= 0.000 
62.47±11.98 
P= 0.000 
51.57±8.75 
P= 0.000 
65.82±16.68 
P= 0.000 
53.31±10.52 
P= 0.000 
Physical 
limitation 
77.79±13.75  73.97±14.82 
P= 0.092 
67.75±14.69 
P= 0.000 
57.36±12.91 
P= 0.000 
69.17±13.25 
P= 0.000 
61.03±14.58 
P= 0.000  Bodily    Pain 
74.98±15.79  58.95±11.43 
P= 0.000 
65.41±14.18 
P= 0.000 
54.97±12.18 
P= 0.000 
64.81±15.56 
P= 0.000 
56.91±14.19 
P= 0.000  General  health 
70.81±15.56  52.84  ±9.94 
P= 0.000 
53.25±9.78 
P= 0.000 
51.39±8.24 
P= 0.000 
53.74±12.81 
P= 0.000 
52.82±13.38 
P= 0.000  Vitality 
87.53±11.38  68.72±11.32 
P= 0.000 
74.85±10.66 
P= 0.000 
65.96±12.52 
P= 0.000 
74.03±14.88 
P= 0.000 
73.37±14.35 
P= 0.000 
Social 
functioning 
85.80±13.87  62.43±12.69 
P= 0.000 
70.05±12.29 
P= 0.000 
59.13±13.81 
P= 0.000 
71.91±13.82 
P= 0.000 
62.71±17.54 
P= 0.000 
Emotional 
limitation 
76.43±16.46  62.95±12.97 
P= 0.000 
69.72±12.16 
P= 0.000 
60.32±12.68 
P= 0.000 
71.71±12.90 
P= 0.001 
61.73±14.46 
P= 0.000  Mental health 
 
 
Discussion 
 
         Voice  is  a  unique  attributes  of 
humans;  provides  a  principal  means  of 
communication,  emotional  expression  and 
identity  (Solomon  et  al.,  2003).  Also,  the 
field  of  laryngology  is  dynamic  and  ever 
changing; at the crossroads is the larynx, a 
barometer of our physical and mental health 
(Aronson, 1980). 
         Spiegel  et  al.  (2000)  stated  that 
laryngitis  is  the  most  common  laryngeal 
diseases.  While,  Herrington-Hall  et  al. 
(1988) and Coyle et al. (2001) cleared that 
the  most  common  diseases  that  cause 
dysphonia  were  vocal  fold  nodules, 
functional dysphonia, vocal fold polyps and 
vocal fold paralysis. This may be explained 
partially  by  the  geographical  and  socio-
cultural  differences  between  the  two 
societies.  The  most  obvious  difference 
between  our results and similar studies  of 
Herrington-Hall et al. (1988) and Coyle et 
al.  (2001)  is  the  presence  2.6%  of  cases 
having  laryngoscleroma,  which  it  is 
documented to be endemic in Egypt (Abou-
Seif et al., 1991 and Thompson, 2002). 
         The  female  gender  (table  2)  was 
found to be a  risk factor for patients  with 
chronic voice disorders (OR=1.32, 95% CI: 
1.02-1.71). Cooper (1973) and Herrington-
Hall  et  al.  (1988)  agreed  with  our  result 
while,  Fitz-Hugh  et  al.  (1958)  disagreed. 
This  may  be  explained  by  the  changes  in 
the socio-cultural aspects of females across 
time. At the same time, Herrington-Hall  et 
al.  (1988)  reported  that  laryngeal 
pathologies  occurred  primarily  in  the  old 
age groups, 57% of their cases were over 45 
years  old  and  22.4%  over  age  64.  Also, 
Coyle  et  al.  (2001)  showed  that  laryngeal 
pathologies occurred most frequent (38.9%) 
in 45-64 years age group, patients in the age 
groups  25-44  years  and  >64  years  were 
26.4% and 26.8% of subjects, respectively. 
So,  our  results  disagree  with  these  studies 
regarding  age.  In  our  study,  there  is 
tendency  for  patients  with  chronic  voice 
disorders due to laryngeal diseases to occur 
in  the  middle  age  group  (25-44  years) 
compared  to  the  oldest  age  category 
commonly affected in Herrington-Hall et al. 
(1988) and Coyle et al. (2001) studies. This 
disagreement  may  have  attributed  to  the 
high  life  expectancy  in  Americans,  public 
awareness and better health education about Risk Factors And Quality Of Life………  
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the association of chronic voice problems in 
western  countries  may  have  influences 
more  adults  to  find  out  the  cause  of 
dysphonia. However, Herrington-Hall et al. 
(1988)  reported  that  the  peak  years  for 
abuse lesions in females were 20-50. Also, 
Holinger and Johnston (1951) stated that of 
significance too was the number of women 
with  small  children  that  they  felt  required 
constant  disciplining.  Likewise,  Cooper 
(1973)  found  that  the  most  common 
occupation  was  that  of  homemaker.  Also, 
Herrington-Hall et al. (1988) stated that it 
seems logic to agree that some occupations 
carry opportunities for voice abuse, as well 
as  emotional  conflicts  that  were  presumed 
to  underlie  psychogenic  disorder.  They 
added that the peak period for abuse lesions 
in  females  was  coinciding  with  the  childe-
rearing  years.  Also,  they  suggested  that 
working  conditions  that  require  speaking 
over noise and breathing irritants in the air, 
as  well  as  physical  exertion  are  possible 
causes of voice disorders in this population. 
In addition,  Cleary (1982)  and Hibbard  & 
Pop  (1986)  cleared  that  women's  number 
was increased in the labor force and cons-
equently  more  exposure  to  occupational 
hazards,  increase  numbers  of  cigarette 
smoking  among  them,  in  addition  to  their 
responsibilities  as  primary  caretakers  of 
home  and  family.  Also,  women  appear  to 
be more interested in health, more likely to 
recognize  bodily  changes  as  symptoms  of 
an illness and more apt to seek medical care 
than  men.  Again,  this  is  in  agreeing  with 
our results that some occupations found to 
be a significant risk factor for a subject to 
be a patient with chronic voice disorders as 
house wife's, factory workers, teachers and 
sale  men.  Moreover,  low  social  class 
represented  a  risk  factor  for  chronic  voice 
disorders. Elwood et al. (1984);  Hirayama 
(1990) and  Menvielle  et  al.  (2004)  agreed 
that  low  social  class  found  to  be  a 
significant risk factor for a subject to be a 
patient with chronic voice disorder. Lastly, 
urban  residence  found  to  be  a  significant 
risk factor for chronic voice disorders. This 
finding  is  expected  and  accepted  in  light 
what  was  previously  mentioned  and  the 
relatively  small  number  of  patients  from 
rural areas.  
         Regarding  voice  abuse  (table  3),  it 
was  an  important  risk  factor  for  chronic 
voice  disorders  (OR=8.33,  95%  CI:  5.97-
11.64).  This  result  was  consistent  with 
Holinger  and  Johnston  (1951);  Cooper 
(1973); Kambic  et al. (1981); Herrington-
Hall et al. (1988); Garcia et al. (1999) and 
Thibeault  et  al.  (2002).  Holinger  and 
Johnston (1951) cleared that the number of 
women with small children, which they felt 
required constant disciplining was significa-
ntly high. Likewise, Cooper (1973) cleared 
that  the  homemakers  were  the  most 
common group with voice disorders. Also, 
Herrington-Hall et al. (1988) supposed that 
voice abuse and the emotional conflicts that 
were underlie psychogenic disorders lead to 
a subject with voice disorders. Garcia et al. 
(1999) showed that voice abuse or misuse 
was  the  main  risk  factor  in  patients  with 
chronic  voice  disorders.  Thibeault  et  al. 
(2002)  cleared  that  vocal  overuse  (exces-
sive quantity of voice), abuse (yelling) and 
misuse (vocal hyperfunction with excessive 
muscular tension) presumably a risk factor 
for voice disorders. As respect smoking, it 
was  a  risk  factor  for  voice  disorders 
(OR=6.01,  95%  CI:  2.29-3.95).  Cigarette 
smoke  is  chronically  irritating  to  the 
laryngeal mucosa and at the extreme it can 
provoke cancer (Hanson and Jiang, 2000). 
Further, Kambic et al. (1981) showed that 
about  50.0%  of  the  patients  with  chronic 
voice disorders were smokers. Also, Garcia 
et  al.  (1999)  found  that  smoking  was  the 
main risk factor for vocal folds polyps and 
edema, which will lead to dysphonia. Also, 
alcohol intake represented a risk factor for 
voice disorders (OR=2.90, 95% ECL: 1.08-
9.05).  This  result  was  consistent  with 
Rothman et al. (1980); Guenel et al. (1988) 
and Altieri et al. (2002).  
         As  respect  results  of  RSI  (table  4), 
+ve RSI was a risk factor for chronic voice 
disorders  (OR=16.94,  95%  CI:  11.80-
24.38). Koufman et al. (1994); El-Serag et 
al. (2001) and Galli et al. (2002) agreed our 
result.  Koufman  et  al.  (1994)  found  that 
50.0%  of  their  population,  new  patients 
with chronic voice disorders due to laryn-
geal  diseases,  had  documented  reflux 
disease. Reflux was also present very frequ-
ently in patients with functional dysphonia. 
On the other hand, reflux was infrequently 
found in patients with vocal fold paralysis. 
         The  females  were  more  commonly 
present  in  most  groups  of  voice  disorder E. A. El-Moselhy et al 
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patients;  chronic  laryngitis,  vocal  fold 
nodules,  functional  dysphonia  and  vocal 
fold polyps (table 5). While, the males were 
more  commonly  present  in  the  miscell-
aneous  diseases  group  of  voice  disorder 
patients.  Previous  studies  of  benign 
laryngeal lesions demonstrated a shift  over 
the  time  as  regard  gender.  Studies  done 
before  1960  (Holinger  &  Johnston,  1951 
and Fitz-Hugh  et  al., 1958)  showed  about 
69.0%  of  lesions  occurred  in  males  and 
31.0% in  females.  Cooper  (1973)  reported 
46.0%  males  and  54.0%  females,  which 
suggested  a  dramatic  shift  in  the 
male/female  percents.  Also,  Herrington-
Hall  et  al.  (1988)  found  similar  results 
when  comparing  benign  lesions  due  to 
abuse  of  the  voice,  a  significant  change 
from  25.0%  of  voice  disorders  found  in 
women  in  1938  to  63.0%  in  their  study. 
Several  reasons  for  this  increase  in 
occurrence in women were hypothesized as 
increased  number  of  women  in  the  labor 
force  and  consequently  more  exposure  to 
occupational  hazards,  increase  numbers  of 
cigarette smoking  among  them,  in  addition 
to  their  responsibilities  as  primary 
caretakers  of  the  home  and  family.  Also, 
some  studies  have  shown  that  women 
appear to be more interested in health, more 
likely  to  recognize  bodily  changes  as 
symptoms of an illness and more apt to seek 
medical  care  than  men  (Cleary,  1982  and 
Hibbard  &  Pop,  1986).  Also,  functional 
voice  disorders  occurred  predominantly  in 
women  (Fried,  1996).  As  regard  age, 
Hanson and Jiang (2002) cleared that adults 
in  the  sixth  decade  of  life  were  mainly 
affected  with  chronic  laryngitis.  Also, 
Herrington-Hall  et  al.  (1988)  detailed  that 
chronic laryngitis occurred more commonly 
in  the  25-44  and  45-64  year  age  groups, 
functional dysphonia  in  the  45-64  and  25-
44  year  age  groups  and  neurogenic 
dysphonia in the oldest age group. Coyle et 
al.  (2001)  showed  that  chronic  laryngitis 
affected more commonly the 45-64 and 25-
44  year  age  groups  and  functional 
dysphonia  in  the  45-64  and  ≥65  year  age 
groups.  The  patients  in  miscellaneous 
diseases  group  (table  5)  were  significantly 
more in the 45-46 year age group. Coyle et 
al. (2001) observed that vocal fold paralysis  
was more commonly affected the 25-44 and 
45-64  year  age  groups,  bowed  vocal  fold 
commonly affected the ≥65 year age group. 
The  25-44  year  age  group  was  the 
commonest age group significantly affected 
with vocal fold nodules in the present study. 
This is consistent with Coyle et al. (2001) 
findings.  However,  Herrington-Hall  et  al. 
(1988)  cleared  that  vocal  fold  nodules 
commonly  affected  the  18-24  year  age 
group. Also, vocal fold polyps were found 
in the present study to occur more in the 25-
44  year  age  group.  Kambic  et  al.  (1981); 
Herrington-Hall et al. (1988) and Coyle et 
al.  (2001)  disagreed  our  result,  they 
reported that vocal fold polyps were found 
to occur more in the 45-64 year age group. 
As respect social class, low social class was 
more present among the chronic laryngitis, 
vocal  fold  nodules,  functional  dysphonia 
and  vocal  fold  polyps  that  caused  chronic 
voice  disorders.  Elwood  et  al.  (1984); 
Hirayama  (1990)  and  Menvielle  et  al. 
(2004) agreed that low social class found to 
be  more  common  among  patients  with 
chronic  voice  disorders.  Lastly,  all  groups 
of patients with chronic voice disorders had 
urban  residence  with  a  statistically  signifi-
cant  difference.  Again,  this  finding  is 
expected and accepted in light of what was 
previously  mentioned  and  the  relatively 
small number of patients from rural areas.  
         Health-related  QOL  represents  the 
functional  effects  of  an  illness  upon  a 
patient as perceived by the patient. “Quality 
of life  reflects a  measure of  the  difference 
or gap between one’s perceived reality and 
one’s  expectations  or  wishes”  (Guillemin  
et al., 1993). Quality of life of well-being is 
a  composite  of  two  components;  first,  the 
ability  to  perform  everyday  activities  that 
reflect  physical,  psychological  and  second, 
social  well-being  and patient  satisfaction 
with levels of functioning and the control of 
disease  and/or  treatment-related  symptoms 
(Gotay  et  al.,  1992).  The  term  QOL  is 
usually  used  vaguely,  without  obvious 
definition  (Fallowfield,  1996).  This  is  not 
surprising, considering the broad nature of a 
concept  that  includes  physical  functioning 
(ability to carry out activities of daily living 
e.g. self care), social functioning (relations-
hips with others and participation in social 
activities),  psychological  functioning 
(emotional  and  mental  well-being)  and 
perception  of  health  status;  pain  and  the 
overall satisfaction with life (Naughton and Risk Factors And Quality Of Life………  
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Shumaker, 1996). QOL is also a subjective 
concept,  multidimensional  scope  that 
requires information about a range of areas 
of patient's life such as physical wellbeing, 
functional  abilities,  emotional  and  social 
wellbeing  (De  Antonio  et  al.,  2001).  In 
addition,  it  is  dynamic,  because  it  often 
changes  across  time  and  situations 
(Aronson, 1980 and Guillemin et al., 1993). 
Also,  QOL  measures  subjective  experi-
ences,  patient  and  professional  can  have 
different  perspectives  on  what  constitutes 
QOL. These  different perspectives  make  it 
difficult to assess QOL (Gotay et al., 1992). 
The  SF-36  broadly  assesses  physical, 
mental and social health and can be used to 
compare  conditions  and  therapies  (Guyatt  
et al., 1986 and Ware & Sherbourne, 1992). 
Further, the SF-36 sensitivity to the prese-
nce  of  otolaryngological  conditions  was 
confirmed.  Otolaryngologists  are  likely  to 
use health status increasingly as health care 
purchasers look for greater accountability in 
expenditure.  The  SF-36  is  a  comprehen-
sively validated instrument and continues to 
be  the  subject  of  an  extensive  program  of 
ongoing  research.  It  is  easy  to  use,  but 
surgeons  must  be  able  to  appreciate  the 
nuances of their findings (Benninger et al., 
1998).  
         In this study the SF-36 questionnaire 
was used to assess the QOL of patients with 
chronic  voice  disorders  due  to  laryngeal 
diseases  and  to  examine  the  differential 
impact  of  chronic  voice  disorders  on  the 
various  health  status  domains.  The  results 
of the present study confirmed that patients 
with  chronic  voice  disorders  due  to 
laryngeal  diseases  had  significantly  poorer 
self- reported health than the controls on all 
the eight SF-36 subscales (P=0.000) (Table 
6). These results, confirm the sensitivity of 
the SF-36 to the presence of oto-laryngolo-
gical  conditions,  agreeing  with  the  results 
of many studies. Smith et al. (1996) demo-
nstrated  considerable  impact  of  dysphonia 
on  patients'  health  status.  Scott    et  al. 
(1997)  illustrated  that  people  with 
dysphonia  experience  social,  lifestyle  and 
employment difficulties as a direct conseq-
uence  of  their  voice  disorders.  Also, 
Benninger et al. (1998) used the SF-36  to 
assess  QOL  in  a  heterogeneous  group  of 
dysphonic  patients;  they  found  significant 
reductions in a number of domains. Wilson 
et  al.  (2002)  compared  self-rated  general 
health status as measured by the SF-36 in a 
large  cohort  of  dysphonic  patients  with 
those  of  control  group  to  examine  the 
differential  impact  of  dysphonia  on  the 
various  health  status  domains.  They 
concluded  that  dysphonic  patients  without 
obvious  laryngeal  disease  have  an  adverse 
impact  on  all  health  status  subscales  as 
measured by the SF-36. 
         When  comparing  the  SF-36  domains 
of  the  different  laryngeal  diseases  separ-
ately  that  caused  chronic  voice  disorders 
with  control  group;  all  domains  were 
significantly lower in patients with chronic 
laryngitis,  vocal  fold  nodules,  functional 
dysphonia,  vocal  fold  polyps  and  miscell-
aneous  diseases  group;  all  scored 
significantly lower in all domains of the SF-
36 than control group except bodily pain in 
the miscellaneous diseases group (Table 7). 
Benninger et al.  (1998) evaluated QOL  of 
the  3  major  etiologies  of  dysphonia; 
masses,  edema  and  vocal  fold  paralysis; 
vocal  fold  paralysis  consistently  demons-
trated  the  worst  scores  of  the  eight  SF-36 
domains.  Also,  Spector  et  al.  (2001)  in  a 
prospective observational outcome study of 
consecutive  patients  presenting  to  a 
laryngology clinic with unilateral vocal fold 
paralysis  to  identify  the  disease  impact  on 
an individual's QOL using the SF-36. They 
cleared  that  patients  revealed  statistically 
significant reductions in QOL. Carrau et al. 
(2004) compared patient-reported outcomes 
health-related  QOL  of  the  patients  with 
laryngopharyngeal  reflux  with  general 
population by the SF-36. They showed that 
it has  a  significant negative  impact  on  the 
lives of patients. 
 
Conclusions And Recommendations 
 
It could be concluded that the most 
common  causes  of  chronic  voice  disorders 
were chronic laryngitis, vocal fold nodules, 
functional dysphonia and vocal fold polyps. 
The 25-44 year age group, low social class, 
some  jobs,  urban  residence  and  female 
gender  were  the  most  important  sociodem-
ographic  risk  factors  of  chronic  voice 
disorders. Also,  +ve  RSI, voice  abuse  and 
smoking  were  important  clinical  risk 
factors. At the same time, the results of the 
study  confirmed  that  patients  with  chronic E. A. El-Moselhy et al 
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voice  disorders  had  significantly  poorer 
self- reported health than the controls on all 
the  eight  SF-36  domains.  These  results 
emphasize  the  need  to  include  a  generic 
QOL outcome measure in the assessment of 
the  patients  with  chronic  voice  disorders. 
So,  it  is  recommended  to  focus  research 
efforts,  health  education  and  clinical 
practices  on  the  chronic  voice  disorders. 
More  work  should  be  conducted  in  more 
areas.  Also,  population  based  studies  are 
needed  to  determine  the  epidemiology  and 
QOL  of  the  patients  with  chronic  voice 
disorders in Egypt. 
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ةايحلا تيعوً و ةروطخلا لهاوع  
يف    تٌهزولا ثوصلا لكاشوب ييباصولا ييغلابلا يضرولا  
 
يحليصولا نعٌولا ذبع ماصع   –   ي ح ي  تكرب نيظعلا ذبع ا –    ذبع ىركش ىاويإ
تللا *  -    
يجبروشلا ىاويلس قراط ** -   وحه ذوحه و واصلا د ى ** -   سورحه جعلط  
يلغرف **  
عوذجولا بط نسق -   -   بط ضَسود لا عوذجو -*   ا ثسجٌحلاو ىذلأاو فًلأ **  
بطلا جُلك   ضَسوذلا و   –   سهشلأا جعهاج   قَشاقصلا و  
 
إ ثحتلا اره يه فدهلا ى    ىه  جدٌهصولا حىدالا صكادئول جع ادئلا ااتدبلأا ددَدحد
جددُااوذجيا ثزىددطةلا صددهاىا دددَدحدو -  ثاددُحلا جددُاىً جددبازةو جُكىلددسلاو جددُفاسجىوَدلا
جٌهصولا حىالا صكائه ًضسول  .  ٍرده خدَسجج ددق و  ًدلا جدبازدلا 561      ادضَسه    يدوه
 يُولاددسلا  اةدد لأا يدده ٌواددسه ةدددا ملرددكو جددٌهصولا حىددالا صكاددئه يدده ىىًاددعَ
 حاُ ددئذسوة ثسددجٌحلاو ىذلأاو فددًلأا ثةاددُا ًددلا يَةةسددذولا يدده جطةاددض جدداىوجوك
سهشلأا جعهاج .      ا دقو مدةذب   ظوً    جطةاضلا جلاحلا جبازة ثحتلا اره ءاسجلإ .  
   ااىُ  ااتبلأا سثكج خًاكو      جٌهصولا حىالا صكائول  7  يهصدولا ثسجٌحلا ااهذلا
( 61.3 )%  جُدىالا حاٌُثلا دقا ، ( 99.3 )%  ٍ ُيىدلا حىالا ااسطضا ، ( 55.3  )%
 جُدىددالا حاددٌُثلا حاددُوحل و ( 56.1  .)% جددُااوذجيا ثزىددطةلا صددهاىا نددهج خددًاكو -
جُ ااحيا جليدلا حاذ جًُاكسلا  7  جَسوعلا جلحسولا 91 - 55   ، ادهاا   ذجيا يىذدسولا  ٍاادو
و ،ًًدذولا    صوعَ ضَسولا ىىك ع اة    ا   ٌدجك ءادسٌلا و ،جدٌَدولا ًٌكبو ، (  شةوج جتدسً  =E. A. El-Moselhy et al 
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5.54  ، 9.15  ، 5.45  ، 5.3    و 5.69   بُدسذلا ًلا  .)  ثزىدطةلا صدهاىا ندهج خدًاك ادوٌُة
 ٌىدددعولا ضهادددحلا  ادددجدزا سهاددداه صدددهاعه ًددده جُ اددداحيا جدددليدلا حاذ جدددُكٌُُلكلأا
دبا ءىبو ،جتجىولا قلحلاو ثسجٌحلاة  يُنددذلاو حىدالا مادةذ (  شةوج جتدسً  = 53.65  ،
5.66    و 3.15   بُدسذلا ًلا  .)    جٌهصولا حىالا صكائه سُثأذل جتسٌلاة و   بتسة     اسدهج
 اىلجددب دددق نددهًج  ياددوجإ دددج و دددقف ًددضسولا ءيقدده ثاددُح جددُاىً ًددلا جددٌهصولا ثسددجٌحلا
ا حيادجولا صددك ًدف مددلذ و جطةادضلا جدداىوجولا ةاسدقج صجددب ادوه صددقج حاَىذدسه  جددًُاوثل
ي ثاُحلا جُاىً ىاُتذب  .    جدٌهصولا حىدالا صكادئول ًضسولا حااىوجه جًزاقوةو    بتدسة
 جُاىً سثأذد حااىوجولا بلغج ىج دج و جطةاضلا جاىوجولاة ج لذةولا ثسجٌحلا  اسهج
ي جدًُاوثلا حيادجولا صدك ًدف مدلذو ًضسولا ءيقهل ثاُحلا  مدلذ و ثادُحلا جدُاىً ىاُتذدب
ذولا جاىوجه ادا اوُف حاقس  .  